CFDB - Cystic Fibrosis DataBase

primary studies published RCT

A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.

Study design (if review, criteria of inclusion for studies)

Single-center, double-blind, placebo controlled, dose ranging study.

Keywords: Adult; Drug Administration Schedule; Gene Transfer Techniques; non pharmacological intervention - genetic& reprod; pharmacological_intervention; placebo;